Hemophilia Treatment Centers (HTCs) help bleeding disorder patients and families manage life with a bleeding disorder, including hemophilia and von Willebrand disease (VWD). They provide comprehensive care including medical care, education, and support services.1
HTCs are part of a system of care with locations throughout the United States and the world.1,2 They are staffed by a care team of professionals with experience in bleeding disorders that includes hematologists, nurses, social workers, physical therapists, and more.1
Although services may vary by treatment center, the following are some of the services typically offered through an HTC1,3,4:
In comprehensive care, a patient is first assigned a team, which varies based on the individual’s needs and the structure of that particular HTC.3 Your team of healthcare providers (HCPs) typically includes hematologists, nurses, social workers, physical therapists, psychologists, and, for female patients, a gynecologist. Some may also have dentists, genetic counselors, and orthopedists.3,4
It’s very important that patients being treated for a bleeding disorder are involved in every aspect of their care. The team takes into account each individual’s needs and lifestyle when planning their treatment.3
“Hold on, don’t take no for an answer, and find doctors who will help you find the treatment that’s best for you.“ — Cathy, hemophilia A patient
Looking for an HCP to help you manage your bleeding disorder? An HTC is staffed with health professionals familiar with treating bleeding disorders.3
From finding a career to planning a family, a bleeding disorder shouldn't hold you back.
Be prepared with questions so you can have better conversations with your healthcare provider.
Get personalized content about news and events in the bleeding disorders community.
Be among the first to get news and information from the Bleeding Disorders Community.
No, thanks
Takeda has been closely monitoring the news surrounding COVID-19. Our highest priority is the health and safety of our community during this uncertain time.
We are taking steps to help ensure the community’s safety including postponing upcoming educational events such as our HELLO TALK® programs. We appreciate your understanding and we will be regularly updating our events on our website.
A global pandemic such as COVID-19 can cause alarm but we urge you to consult with your healthcare provider to discuss questions regarding your condition and COVID-19. In addition, the CDC (Centers for Disease Control and Prevention) website includes information on things like COVID-19 symptoms, how to protect yourself and others from the virus, and who may be at higher risk for complications due to the virus. The National Hemophilia Foundation and the Hemophilia Federation of America are also helpful resources for patients with bleeding disorders and caregivers.
For those of you who are currently on Takeda treatments, based on current assessments of our global supply chain, we do not anticipate any potential supply disruption in the near-term due to the Coronavirus outbreak. Longer-term, it is not yet possible to predict precisely what the impact may be on individual products. We will continue to monitor the situation as it evolves and take all necessary actions in an effort to ensure supply continuity for the people we serve. Rest assured, we will keep patient advocacy organizations and health care providers informed of any material changes in status.
If you have been prescribed a Takeda therapy and have questions, you can call our Hematology Support Center at 888-229-8379 Monday through Friday from 8:30 AM to 8:00 PM.
We are in this together with you.
